These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17011825)

  • 1. Evidence of recurrent gene fusions in common epithelial tumors.
    Kumar-Sinha C; Tomlins SA; Chinnaiyan AM
    Trends Mol Med; 2006 Nov; 12(11):529-36. PubMed ID: 17011825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The discovery of common recurrent transmembrane protease serine 2 (TMPRSS2)-erythroblastosis virus E26 transforming sequence (ETS) gene fusions in prostate cancer: significance and clinical implications.
    Shah RB; Chinnaiyan AM
    Adv Anat Pathol; 2009 May; 16(3):145-53. PubMed ID: 19395877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer.
    Tomlins SA; Mehra R; Rhodes DR; Smith LR; Roulston D; Helgeson BE; Cao X; Wei JT; Rubin MA; Shah RB; Chinnaiyan AM
    Cancer Res; 2006 Apr; 66(7):3396-400. PubMed ID: 16585160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetic analyses of the TMPRSS2-ERG and TMPRSS2-ETV1 gene fusions in 50 cases of prostate cancer.
    Winnes M; Lissbrant E; Damber JE; Stenman G
    Oncol Rep; 2007 May; 17(5):1033-6. PubMed ID: 17390040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
    Tomlins SA; Laxman B; Dhanasekaran SM; Helgeson BE; Cao X; Morris DS; Menon A; Jing X; Cao Q; Han B; Yu J; Wang L; Montie JE; Rubin MA; Pienta KJ; Roulston D; Shah RB; Varambally S; Mehra R; Chinnaiyan AM
    Nature; 2007 Aug; 448(7153):595-9. PubMed ID: 17671502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer.
    Helgeson BE; Tomlins SA; Shah N; Laxman B; Cao Q; Prensner JR; Cao X; Singla N; Montie JE; Varambally S; Mehra R; Chinnaiyan AM
    Cancer Res; 2008 Jan; 68(1):73-80. PubMed ID: 18172298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphologic features of carcinomas with recurrent gene fusions.
    Qi M; Li Y; Liu J; Yang X; Wang L; Zhou Z; Han B
    Adv Anat Pathol; 2012 Nov; 19(6):417-24. PubMed ID: 23060067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal aberrations in solid tumors.
    Chinnaiyan AM; Palanisamy N
    Prog Mol Biol Transl Sci; 2010; 95():55-94. PubMed ID: 21075329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Frequent gene fusion in prostate cancer: clinical applications in diagnosis, prognosis and therapy].
    Schmidt F; Scheble V; Mertz K; Perner S; Rubin MA
    Dtsch Med Wochenschr; 2009 Jul; 134(28-29):1483-6. PubMed ID: 19572250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic gene fusions in epithelial carcinomas.
    Prensner JR; Chinnaiyan AM
    Curr Opin Genet Dev; 2009 Feb; 19(1):82-91. PubMed ID: 19233641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of translocations and gene fusions on cancer causation.
    Mitelman F; Johansson B; Mertens F
    Nat Rev Cancer; 2007 Apr; 7(4):233-45. PubMed ID: 17361217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ETS gene fusions in prostate cancer: from discovery to daily clinical practice.
    Tomlins SA; Bjartell A; Chinnaiyan AM; Jenster G; Nam RK; Rubin MA; Schalken JA
    Eur Urol; 2009 Aug; 56(2):275-86. PubMed ID: 19409690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissecting prostate carcinogenesis through ETS gene rearrangement studies: implications for anticancer drug development.
    Attard G; Ang JE; Olmos D; de Bono JS
    J Clin Pathol; 2008 Aug; 61(8):891-6. PubMed ID: 18495790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHCHD7-PLAG1 and TCEA1-PLAG1 gene fusions resulting from cryptic, intrachromosomal 8q rearrangements in pleomorphic salivary gland adenomas.
    Asp J; Persson F; Kost-Alimova M; Stenman G
    Genes Chromosomes Cancer; 2006 Sep; 45(9):820-8. PubMed ID: 16736500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent gene fusions in prostate cancer: their clinical implications and uses.
    Hessels D; Schalken JA
    Curr Urol Rep; 2013 Jun; 14(3):214-22. PubMed ID: 23625457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumor-type specific translocations methods and indications for routine molecular pathology].
    Gattenlöhner S; Müller-Hermelink HK
    Verh Dtsch Ges Pathol; 2007; 91():154-9. PubMed ID: 18314609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer.
    Hermans KG; Bressers AA; van der Korput HA; Dits NF; Jenster G; Trapman J
    Cancer Res; 2008 May; 68(9):3094-8. PubMed ID: 18451133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.
    Jiang M; Li M; Fu X; Huang Y; Qian H; Sun R; Mao Y; Xie Y; Li Y
    Prostate; 2008 Oct; 68(14):1496-509. PubMed ID: 18366025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA expression profiling in prostate cancer.
    Porkka KP; Pfeiffer MJ; Waltering KK; Vessella RL; Tammela TL; Visakorpi T
    Cancer Res; 2007 Jul; 67(13):6130-5. PubMed ID: 17616669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fusion genes and transcripts in neoplasia].
    Kekeeva TV; Zavalishina LÉ; Frank GA; Zaletaev DV
    Mol Biol (Mosk); 2011; 45(5):793-804. PubMed ID: 22393775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.